Results 161 to 170 of about 5,691,277 (301)

Has Australia lost control of its tobacco and nicotine markets?

Addiction, EarlyView.
Abstract Background Australia has adopted two policies that the World Health Organization (WHO) recommends as best practice for tobacco control: it has steeply increased tobacco taxes since 2010 and only allowed access to nicotine vapes for medical use.
Ron Borland, James Martin, Edward Jegasothy, Ben Youdan, Wayne Hall   +4 more
wiley   +1 more source

UK Medical Cannabis Registry: An Updated Analysis of Inflammatory Arthritis. [PDF]

Clin Med Insights Arthritis Musculoskelet Disord
Sajeev A, Erridge S, Datta A, Clarke E, McLachlan K, Coomber R, Rucker JJ, Platt M, Sodergren MH.   +8 more
europepmc   +1 more source

The psychometric properties of validated tools to assess cannabis use disorder: A systematic review and meta‐analysis

Addiction, EarlyView.
Abstract Aims To systematically review the evidence on the psychometric performance and accuracy of screening or diagnostic tools for cannabis use disorder. Method Systematic review and meta‐analysis which included studies conducted in clinical settings, schools, universities, community settings and population‐based surveys in multiple countries and ...
Janni Leung, Daniel Stjepanovic, Stephanie Fong, Danielle Dawson, Giang Vu, Tesfa Yimer, Caitlin McClure‐Thomas, Wayne Denis Hall, Gary Chung Kai Chan   +8 more
wiley   +1 more source

Medical Cannabis and the Hallmarks of Cancer: A Critical Narrative Review. [PDF]

Int J Mol Sci
Russo D, Fernandes R, Tavares V, Agrelo A, Medeiros R.   +4 more
europepmc   +1 more source

Chronic Disease Symptoms Self-Managed by Cannabis During the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study

The COVID-19 pandemic has impacted billions of people worldwide, particularly those with chronic health conditions, and has been associated with increases in substance use, including cannabis.
Camacho-Rivera, Marlene, Islam, Jessica Y, O'Dell, Nicole, Baral, Amrit, Reid, Marvin, Ortega, Johis, Vidot, Denise C, Diggs, Bria-Necole A   +7 more
core   +1 more source

Cross‐sectional and longitudinal associations of cannabis use with cognitive functioning in individuals with a cannabis use disorder: The moderating role of nicotine

Addiction, EarlyView.
Abstract Background and Aims Cannabis is among the most widely used psychoactive substances globally and is often consumed alongside tobacco. Cannabis use has been associated with impairments in attention, learning, and memory, whereas nicotine can acutely enhance, but chronically impair, certain cognitive functions.
Emese Kroon, Nora de Bode, Karis Colyer‐Patel, Jia Hua Hsieh, Francesca Filbey, Janna Cousijn   +5 more
wiley   +1 more source

Medical Cannabis During Pregnancy and Breastfeeding: Is the Concern Fully Evidence-Based? [PDF]

Biomedicines
Pevzner M, Sasson D, Porat C, Porat D, Dahan A.   +4 more
europepmc   +1 more source

Brain reward function in young people with cannabis use disorder: A functional magnetic resonance imaging study

Addiction, EarlyView.
Abstract Background and Aims Cannabis use disorder (CUD) affects ~50 million people globally. Neuroscientific theories suggest that a blunted neural response to non‐drug rewards is a hallmark of substance use disorders; however, this remains untested in CUD. The current study tested whether brain reward system responses to the anticipation and feedback
Martine Skumlien, Lisa‐Marie Greenwood, Arush Honnedevasthana Arun, Isabella Goodwin, Anastasia Paloubis, Tribikram Thapa Rana, Marianna Quinones Valera, Eugene McTavish, Gabrielle Abbott, Suraya Dunsford, Antonio Verdejo‐Garcia, Jessica Ramamurthy, Mark M. Schira, Nadia Solowij, Chao Suo, Valentina Lorenzetti   +15 more
wiley   +1 more source

Prevalence and risk perceptions of nicotine pouch use: A systematic review of population‐based studies

Addiction, EarlyView.
Abstract Background and Aims Oral nicotine pouches (NPs) are a new class of non‐combustible nicotine products that have gained rapid popularity. Despite rising sales and marketing, evidence of their prevalence and risk perceptions remains limited. This systematic review aimed to synthesize the available global evidence on the prevalence and patterns of
Salma Mahmoodianfard, Spencer Shahen, Javad Heshmati, Emma Bates, Evyanne Quirouette, Terefe Gelibo, Sarah Visintini, Hassan Mir   +7 more
wiley   +1 more source

UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Autism Spectrum Disorder. [PDF]

Neuropsychopharmacol Rep
Aggarwal A, Erridge S, Varadpande M, Clarke E, McLachlan K, Coomber R, Asghar M, Bhoskar U, Crews M, De Angelis A, Imran M, Kamal F, Korb L, Mwimba G, Sachdeva-Mohan S, Shaya G, Rucker JJ, Sodergren MH.   +17 more
europepmc   +1 more source